124 related articles for article (PubMed ID: 16401279)
1. MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.
Wu D; Rosner GL; Broemeling L
Biometrics; 2005 Dec; 61(4):1056-63. PubMed ID: 16401279
[TBL] [Abstract][Full Text] [Related]
2. Bayesian inference for the lead time in periodic cancer screening.
Wu D; Rosner GL; Broemeling LD
Biometrics; 2007 Sep; 63(3):873-80. PubMed ID: 17825017
[TBL] [Abstract][Full Text] [Related]
3. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
[TBL] [Abstract][Full Text] [Related]
4. Bayesian evaluation of breast cancer screening using data from two studies.
Myles JP; Nixon RM; Duffy SW; Tabar L; Boggis C; Evans G; Shenton A; Howell A
Stat Med; 2003 May; 22(10):1661-74. PubMed ID: 12720303
[TBL] [Abstract][Full Text] [Related]
5. [A study on scheduling periodic examinations for the early detection of breast cancer in Korea].
Jeong SH; Kang DR; Hur NW; Kim J; Lee SY; Jung SH; Nam CM
J Prev Med Public Health; 2006 Jul; 39(4):346-52. PubMed ID: 16910309
[TBL] [Abstract][Full Text] [Related]
6. Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution.
Shen Y; Zelen M
Biostatistics; 2005 Oct; 6(4):604-14. PubMed ID: 15860542
[TBL] [Abstract][Full Text] [Related]
7. Scheduling mammography screening for the early detection of breast cancer in Korean women.
Lee SY; Jeong SH; Kim J; Jung SH; Song KB; Nam CM
J Med Screen; 2007; 14(4):205-9. PubMed ID: 18078566
[TBL] [Abstract][Full Text] [Related]
8. Estimation of age-specific sensitivity and sojourn time in breast cancer screening studies.
Cong XJ; Shen Y; Miller AB
Stat Med; 2005 Oct; 24(20):3123-38. PubMed ID: 15977269
[TBL] [Abstract][Full Text] [Related]
9. Inference on cancer screening exam accuracy using population-level administrative data.
Jiang H; Brown PE; Walter SD
Stat Med; 2016 Jan; 35(1):130-46. PubMed ID: 26278587
[TBL] [Abstract][Full Text] [Related]
10. Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.
Chen Y; Brock G; Wu D
Cancer Epidemiol; 2010 Aug; 34(4):429-33. PubMed ID: 20434974
[TBL] [Abstract][Full Text] [Related]
11. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
12. [Economic approach to breast cancer screening in Belgium].
Grivegnée AR; Autier P
Rev Med Brux; 2001 Sep; 22(4):A277-81. PubMed ID: 11680188
[TBL] [Abstract][Full Text] [Related]
13. The association between obesity and screening mammography accuracy.
Elmore JG; Carney PA; Abraham LA; Barlow WE; Egger JR; Fosse JS; Cutter GR; Hendrick RE; D'Orsi CJ; Paliwal P; Taplin SH
Arch Intern Med; 2004 May; 164(10):1140-7. PubMed ID: 15159273
[TBL] [Abstract][Full Text] [Related]
14. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
15. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.
Berry DA; Inoue L; Shen Y; Venier J; Cohen D; Bondy M; Theriault R; Munsell MF
J Natl Cancer Inst Monogr; 2006; (36):30-6. PubMed ID: 17032892
[TBL] [Abstract][Full Text] [Related]
16. Physician and Nonphysician Estimates of Positive Predictive Value in Diagnostic v. Mass Screening Mammography: An Examination of Bayesian Reasoning.
Austin LC
Med Decis Making; 2019 Feb; 39(2):108-118. PubMed ID: 30678607
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer screening methods: a review of the evidence.
Vahabi M
Health Care Women Int; 2003 Nov; 24(9):773-93. PubMed ID: 14742116
[TBL] [Abstract][Full Text] [Related]
18. Estimation of sensitivity depending on sojourn time and time spent in preclinical state.
Kim S; Wu D
Stat Methods Med Res; 2016 Apr; 25(2):728-40. PubMed ID: 23129110
[TBL] [Abstract][Full Text] [Related]
19. Benefits and risks of screening mammography for women in their forties: a statistical appraisal.
Berry DA
J Natl Cancer Inst; 1998 Oct; 90(19):1431-9. PubMed ID: 9776408
[No Abstract] [Full Text] [Related]
20. The lead time distribution when lifetime is subject to competing risks in cancer screening.
Wu D; Kafadar K; Rosner GL; Broemeling LD
Int J Biostat; 2012; 8(1):. PubMed ID: 22611589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
